Stress and Memory: A Selective Review on Recent Developments in the Understanding of Stress Hormone Effects on Memory and Their Clinical Relevance

Journal of Neuroendocrinology

Volumn 28, Issue 8, 2016, Pages

  Wolf, O T ^a   Atsak, P ^b,c   de Quervain, D J ^d   Roozendaal, B ^b,c   Wingenfeld, K ^e  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d UNIVERSITY OF BASEL   (Switzerland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

aldosterone; cortisol corticosterone; glucocorticoids; membrane nuclear; mineralocorticoids; norepinephrine; receptors

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; ENDOCANNABINOID; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; NORADRENALIN; STRESS HORMONE; MINERALOCORTICOID;

ADJUVANT THERAPY; ANXIETY DISORDER; AROUSAL; COGNITION; CONDITIONED REFLEX; EMOTIONALITY; FEAR; FEAR CONDITIONING TEST; HUMAN; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; STRESS; ANIMAL; BRAIN; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REINFORCEMENT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; ENDOCANNABINOIDS; EXTINCTION, PSYCHOLOGICAL; FEAR; GLUCOCORTICOIDS; HUMANS; MEMORY; MEMORY CONSOLIDATION; MINERALOCORTICOIDS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84984877009     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12353     Document Type: Review

References (88)

1. Joëls M, Pu Z, Wiegert O, Oitzl MS, Krugers HJ. Learning under stress: how does it work? Trends Cogn Sci 2006; 10: 152–158.
2. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat Rev Neurosci 2009; 10: 423–433.
3. Sandi C, Pinelo-Nava MT. Stress and memory: behavioral effects and neurobiological mechanisms. Neural Plast 2007; 2007: 78970.
4. McGaugh JL, Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol 2002; 12: 205–210.
5. Wolf OT. The influence of stress hormones on emotional memory: relevance for psychopathology. Acta Psychol (Amst) 2008; 127: 513–531.
6. Schelling G, Roozendaal B, de Quervain DJ. Can posttraumatic stress disorder be prevented with glucocorticoids? Ann NY Acad Sci 2004; 1032: 158–166.
7. Roozendaal B. Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 2002; 78: 578–595.
8. de Quervain DJ, Aerni A, Schelling G, Roozendaal B. Glucocorticoids and the regulation of emotional memory in health and disease. Front Neuroendocrinol 2009; 30: 358–370.
9. Wolf OT. Stress and memory in humans: twelve years of progress? Brain Res 2009; 1293: 142–154.
10. Quirarte GL, Roozendaal B, McGaugh JL. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 1997; 94: 14048–14053.
11. Joëls M, Karst H, DeRijk R, De Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci 2008; 31: 1–7.
12. De Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6: 463–475.
13. Dallman MF. Fast glucocorticoid actions on brain: back to the future. Front Neuroendocrinol 2005; 26: 103–108.
14. McIntyre CK, Hatfield T, McGaugh JL. Amygdala norepinephrine levels after training predict inhibitory avoidance retention performance in rats. Eur J Neurosci 2002; 16: 1223–1226.
15. McReynolds JR, Donowho K, Abdi A, McGaugh JL, Roozendaal B, McIntyre CK. Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions. Neurobiol Learn Mem 2010; 93: 312–321.
16. Atsak P, Roozendaal B, Campolongo P. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 2012; 204: 104–116.
17. Hill MN, McEwen BS. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 791–797.
18. Tasker JG, Herman JP. Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress 2011; 14: 398–406.
19. Hashimotodani Y, Ohno-Shosaku T, Kano M. Endocannabinoids and synaptic function in the CNS. Neuroscientist 2007; 13: 127–137.
20. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83: 1017–1066.
21. Atsak P, Hauer D, Campolongo P, Schelling G, Fornari RV, Roozendaal B. Endocannabinoid signaling within the basolateral amygdala integrates multiple stress hormone effects on memory consolidation. Neuropsychopharmacology 2015; 40: 1485–1494.
22. Sachser RM, Crestani AP, Quillfeldt JA, Mello E Souza T, de Oliveira AL. The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction. Learn Mem 2015; 22: 584–588.
23. Roozendaal B, Quirarte GL, McGaugh JL. Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor–cAMP/cAMP/PKA system in influencing memory consolidation. Eur J Neurosci 2002; 15: 553–560.
24. Hill MN, McEwen BS. Endocannabinoids: the silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci USA 2009; 106: 4579–4580.
25. Morena M, Roozendaal B, Trezza V, Ratano P, Peloso A, Hauer D, Atsak P, Trabace L, Cuomo V, McGaugh JL, Schelling G, Campolongo P. Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training. Proc Natl Acad Sci USA 2014; 111: 18333–18338.
26. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001; 21: 9506–9518.
27. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgansberger W, Rammes G. Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 2004; 24: 9953–9961.
28. de Oliveira Alvares L, Engelke DS, Diehl F, Scheffer-Teixeira R, Haubrich J, de Freitas CL, Molina VA, Quillfeldt JA. Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem 2010; 17: 202–209.
29. Atsak P, Hauer D, Campolongo P, Schelling G, McGaugh JL, Roozendaal B. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proc Natl Acad Sci USA 2012; 109: 3504–3509.
30. Morena M, De Castro V, Gray JM, Palmery M, Trezza V, Roozendaal B, Hill MN, Campolongo P. Training-associated emotional arousal shapes endocannabinoid modulation of spatial memory retrieval in rats. J Neurosci 2015; 35: 13962–13974.
31. Cornelisse S, Joëls M, Smeets T. A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology 2011; 36: 2720–2728.
32. Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K, Kellner M. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 2007; 32: 232–238.
33. Rimmele U, Besedovsky L, Lange T, Born J. Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology 2013; 38: 884–894.
34. Harris AP, Holmes MC, De Kloet ER, Chapman KE, Seckl JR. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology 2013; 38: 648–658.
35. Hinkelmann K, Wingenfeld K, Kuehl LK, Fleischer J, Heuser I, Wiedemann K, Otte C. Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals. Neurobiol Aging 2015; 36: 919–924.
36. Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A, Regen F, Bajbouj M, Zimmermann-Viehoff F, Wiedemann K, Hinkelmann K. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology 2015; 40: 386–393.
37. Wingenfeld K, Kuehl LK, Janke K, Hinkelmann K, Eckert FC, Roepke S, Otte C. Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder. Neurobiol Learn Mem 2015; 120: 94–100.
38. Wingenfeld K, Wolf OT. HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions. CNS Neurosci Ther 2011; 17: 714–722.
39. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12: 342–348.
40. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 2002; 7; 985–994, 924.
41. Lembke A, Gomez R, Tenakoon L, Keller J, Cohen G, Williams GH, Kraemer FB, Schatzberg AF. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology 2013; 38: 115–121.
42. Klok MD, Alt SR, Irurzun Lafitte AJ, Turner JD, Lakke EA, Huitinga I, Muller CP, Zitman FG, De Kloet ER, Derijk RH. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiatr Res 2011; 45: 871–878.
43. Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W Jr, Myers RM, Schatzberg A, Akil H, Watson SJ. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J Psychiatr Res 2013; 47: 307–314.
44. Schlosser N, Wolf OT, Wingenfeld K. Cognitive correlates of hypothalamic-pituitary-adrenal axis in major dpressive disorder. Expert Rev Endocrinol Metab 2011; 6: 109–126.
45. Hinkelmann K, Moritz S, Botzenhardt J, Riedesel K, Wiedemann K, Kellner M, Otte C. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry 2009; 66: 879–885.
46. Rubinow DR, Post RM, Savard R, Gold PW. Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry 1984; 41: 279–283.
47. Ferguson D, Sapolsky R. Mineralocorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory. J Neurosci 2007; 27: 8046–8052.
48. Joëls M, Krugers HJ. LTP after stress: up or down? Neural Plast 2007; 2007: 93202.
49. Joëls M, Fernandez G, Roozendaal B. Stress and emotional memory: a matter of timing. Trends Cogn Sci 2011; 15: 280–288.
50. Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008; 33: 56–72.
51. Maren S, Holmes A. Stress and fear extinction. Neuropsychopharmacology 2016; 41: 58–79.
52. de Quervain DJ, Bentz D, Michael T, Bolt OC, Wiederhold BK, Margraf J, Wilhelm FH. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci USA 2011; 108: 6621–6625.
53. Jacobs WJ, Nadel L. Stress-induced recovery of fears and phobias. Psychol Rev 1985; 92: 512–531.
54. Hamacher-Dang TC, Uengoer M, Wolf OT. Stress impairs retrieval of extinguished and unextinguished associations in a predictive learning task. Neurobiol Learn Mem 2013; 104: 1–8.
55. Merz CJ, Hamacher-Dang TC, Wolf OT. Exposure to stress attenuates fear retrieval in healthy men. Psychoneuroendocrinology 2014; 41: 89–96.
56. Bouton ME. Context and behavioral processes in extinction. Learn Mem 2004; 11: 485–494.
57. Kuhlmann S, Piel M, Wolf OT. Impaired memory retrieval after psychosocial stress in healthy young men. J Neurosci 2005; 25: 2977–2982.
58. Wolf OT, Schommer NC, Hellhammer DH, Reischies FM, Kirschbaum C. Moderate psychosocial stress appears not to impair recall of words learned four weeks prior to stress exposure. Stress 2002; 5: 59–64.
59. Schwabe L, Wolf OT. Stress and multiple memory systems: from ‘thinking’ to ‘doing’. Trends Cogn Sci 2013; 17: 60–68.
60. Hamacher-Dang TC, Engler H, Schedlowski M, Wolf OT. Stress enhances the consolidation of extinction memory in a predictive learning task Front. Behav Neurosci 2013; 7: 108.
61. Hamacher-Dang TC, Merz CJ, Wolf OT. Stress following extinction learning leads to a context-dependent return of fear. Psychophysiology 2015; 52: 489–498.
62. Cordero MI, Sandi C. A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity. Brain Res 1998; 786: 11–17.
63. Pugh CR, Tremblay D, Fleshner M, Rudy JW. A selective role for corticosterone in contextual-fear conditioning. Behav Neurosci 1997; 111: 503–511.
64. Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci 2009; 12: 256–258.
65. Soeter M, Kindt M. An abrupt transformation of phobic behavior after a post-retrieval amnesic agent. Biol Psychiatry 2015; 78: 880–886.
66. Meir Drexler S, Merz CJ, Hamacher-Dang TC, Tegenthoff M, Wolf OT. Effects of cortisol on reconsolidation of reactivated fear memories. Neuropsychopharmacology 2015; 40: 3036–3043.
67. Buchanan TW, Lovallo WR. Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 2001; 26: 307–317.
68. De Kloet ER, Oitzl MS, Joëls M. Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci 1999; 22: 422–426.
69. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171–179.
70. Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, Nitsch RM, Schnyder U, de Quervain DJ. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 2004; 161: 1488–1490.
71. Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U, Roozendaal B, de Quervain DJ. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci USA 2006; 103: 5585–5590.
72. Yehuda R, Bierer LM, Pratchett LC, Lehrner A, Koch EC, Van Manen JA, Flory JD, Makotkine I, Hildebrandt T. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology 2015; 51: 589–597.
73. Cai WH, Blundell J, Han J, Greene RW, Powell CM. Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci 2006; 26: 9560–9566.
74. Soravia LM, Heinrichs M, Winzeler L, Fisler M, Schmitt W, Horn H, Dierks T, Strik W, Hofmann SG, de Quervain DJ. Glucocorticoids enhance in vivo exposure based therapy of spider phobia. Depress Anxiety 2014; 31: 429–435.
75. Walter M, Bentz D, Schicktanz N, Milnik A, Aerni A, Gerhards C, Schwegler K, Vogel M, Blum J, Schmid O, Roozendaal B, Lang UE, Borgwardt S, de Quervain DJ. Effects of cortisol administration on craving in heroin addicts Transl. Psychiatry 2015; 5: e610.
76. Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004; 44: 161–179.
77. Preller KH, Wagner M, Sulzbach C, Hoenig K, Neubauer J, Franke PE, Petrovsky N, Frommann I, Rehme AK, Quednow BB. Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users. Eur Neuropsychopharmacol 2013; 23: 1270–1279.
78. Ackermann S, Heck A, Rasch B, Papassotiropoulos A, de Quervain DJ. The BclI polymorphism of the glucocorticoid receptor gene is associated with emotional memory performance in healthy individuals. Psychoneuroendocrinology 2013; 38: 1203–1207.
79. Hauer D, Weis F, Papassotiropoulos A, Schmoeckel M, Beiras-Fernandez A, Lieke J, Kaufmann I, Kirchhoff F, Vogeser M, Roozendaal B, Briegel J, DE QD, Schelling G. Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 2011; 39: 643–650.
80. Vukojevic V, Kolassa IT, Fastenrath M, Gschwind L, Spalek K, Milnik A, Heck A, Vogler C, Wilker S, Demougin P, Peter F, Atucha E, Stetak A, Roozendaal B, Elbert T, Papassotiropoulos A, de Quervain DJ. Epigenetic modification of the glucocorticoid receptor gene is linked to traumatic memory and post-traumatic stress disorder risk in genocide survivors. J Neurosci 2014; 34: 10274–10284.
81. Yehuda R, Flory JD, Bierer LM, Henn-Haase C, Lehrner A, Desarnaud F, Makotkine I, Daskalakis NP, Marmar CR, Meaney MJ. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry 2015; 77: 356–364.
82. Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann NY Acad Sci 1071; 2006: 137–166.
83. Hauer D, Schelling G, Gola H, Campolongo P, Morath J, Roozendaal B, Hamuni G, Karabatsiakis A, Atsak P, Vogeser M, Kolassa IT. Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder. PLoS ONE 2013; 8: e62741.
84. Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology 2013; 38: 2952–2961.
85. Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, Ropchan J, Henry S, Corsi-Travali S, Carson RE, Huang Y. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry 2013; 18: 1034–1040.
86. Krystal JH, Neumeister A. Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Res 2009; 1293: 13–23.
87. de Quervain DJ, Margraf J. Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach. Eur J Pharmacol 2008; 583: 365–371.
88. Yehuda R, Daskalakis NP, Desarnaud F, Makotkine I, Lehrner AL, Koch E, Flory JD, Buxbaum JD, Meaney MJ, Bierer LM. Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD front. Psychiatry 2013; 4: 118.